Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), consisting of a 44-amino acid sequence modified with a trans-3-hexenoic acid group at its N-terminal position. This specific structural optimization significantly enhances its stability and resistance to enzymatic degradation compared to natural GHRH, allowing for more prolonged molecular interaction with pituitary receptors.

In laboratory and metabolic models, researchers study Tesamorelin to evaluate its ability to stimulate the synthesis and pulsatile secretion of endogenous growth hormone (GH) without causing rapid depletion of pituitary stores.

Current Areas of Investigation

• Pituitary GHRH receptor binding and activation

• Lipolysis and visceral adipose tissue (VAT) reduction

• Lipid profile optimization and metabolic homeostasis

• Preservation of lean muscle mass during adipose breakdown

Research Focus

Technical Specifications

Appearance

Lyophilized white powder

Storage Requirements

Store desiccated at −20°C for long-term molecular stability.

Research Disclaimer

Tesamorelin supplied by Nomad Clinical is intended exclusively for laboratory research purposes. It is not approved as a medicinal product or food supplement and is not intended for human or veterinary use. References to published scientific literature are provided for educational purposes to summarize current areas of research and should not be interpreted as claims regarding the safety, efficacy, or intended use of this product.